Cargando…

Selection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer

The use of bacteriophages to select novel ligands has been widely explored for cancer therapy. Their application is most warranted in cancer subtypes lacking knowledge on how to target the cancer cells in question, such as the triple negative breast cancer, eventually leading to the development of a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Vera L., Ferreira, Debora, Nobrega, Franklin L., Martins, Ivone M., Kluskens, Leon D., Rodrigues, Ligia R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993384/ https://www.ncbi.nlm.nih.gov/pubmed/27548261 http://dx.doi.org/10.1371/journal.pone.0161290

Ejemplares similares

Screening and characterization of novel specific peptides targeting MDA-MB-231 claudin-low breast carcinoma by computer-aided phage display methodologies
por: Nobrega, Franklin L., et al.
Publicado: (2016)

Triple Negative Breast Cancer: Nanosolutions for a Big Challenge
por: Mendes, Tânia Filipa S., et al.
Publicado: (2015)

Rational Identification of a Colorectal Cancer Targeting Peptide through Phage Display
por: Ferreira, Débora, et al.
Publicado: (2019)

Selection of aptamers against triple negative breast cancer cells using high throughput sequencing
por: Ferreira, Débora, et al.
Publicado: (2021)

Genetically manipulated phages with improved pH resistance for oral administration in veterinary medicine
por: Nobrega, Franklin L., et al.
Publicado: (2016)

Dissecting the heterogeneity of the alternative polyadenylation profiles in triple-negative breast cancers
por: Wang, Lei, et al.
Publicado: (2020)

Development of CAPER peptides for the treatment of triple negative breast cancer
por: Chilewski, Shannon D., et al.
Publicado: (2020)

The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC)
por: Narrandes, Shavira, et al.
Publicado: (2018)

Exploring specific prognostic biomarkers in triple-negative breast cancer
por: Bao, Chang, et al.
Publicado: (2019)

The Heparan Sulfate Binding Peptide in Tumor Progression of Triple-Negative Breast Cancer
por: Melo, Carina Mucciolo, et al.
Publicado: (2021)

The Functional Impact of Alternative Splicing on the Survival Prognosis of Triple-Negative Breast Cancer
por: Wu, Sijia, et al.
Publicado: (2021)

The development of activatable lytic peptides for targeting triple negative breast cancer
por: Zhao, Hui, et al.
Publicado: (2017)

Peptide density targets and impedes triple negative breast cancer metastasis
por: Liu, Daxing, et al.
Publicado: (2018)

Structural and Enzymatic Characterization of ABgp46, a Novel Phage Endolysin with Broad Anti-Gram-Negative Bacterial Activity
por: Oliveira, Hugo, et al.
Publicado: (2016)

The role of melatonin on miRNAs modulation in triple-negative breast cancer cells
por: Ferreira, Lívia C., et al.
Publicado: (2020)

Revitalizing the AZT Through of the Selenium: An Approach in Human Triple Negative Breast Cancer Cell Line
por: Wagner, Mônica Silveira, et al.
Publicado: (2018)

Characterization of inorganic phosphate transport in the triple-negative breast cancer cell line, MDA-MB-231
por: Russo-Abrahão, Thais, et al.
Publicado: (2018)

Small Peptide Ligands for Targeting EGFR in Triple Negative Breast Cancer Cells
por: Hossein-Nejad-Ariani, Hanieh, et al.
Publicado: (2019)

Exploring the Application of Bifunctional Metal Chelators in Treating Triple-Negative Breast Cancer
por: Li, Kuo, et al.
Publicado: (2021)

A Thermostable Salmonella Phage Endolysin, Lys68, with Broad Bactericidal Properties against Gram-Negative Pathogens in Presence of Weak Acids
por: Oliveira, Hugo, et al.
Publicado: (2014)

Integrated Design of a Membrane‐Lytic Peptide‐Based Intravenous Nanotherapeutic Suppresses Triple‐Negative Breast Cancer
por: Chen, Charles H., et al.
Publicado: (2022)

Characterization of Contaminants from a Sanitized Milk Processing Plant
por: Cleto, Sara, et al.
Publicado: (2012)

Novel Insights Into Triple-Negative Breast Cancer Prognosis by Comprehensive Characterization of Aberrant Alternative Splicing
por: Gong, Shasha, et al.
Publicado: (2020)

Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer
por: Wang, Longkun, et al.
Publicado: (2023)

Machine learning-driven exploration of drug therapies for triple-negative breast cancer treatment
por: Kaushik, Aman Chandra, et al.
Publicado: (2023)

Exploring Real-World HER2-Low Data in Early-Stage Triple-Negative Breast Cancer: Insights and Implications
por: da Silva, Jesse Lopes, et al.
Publicado: (2023)

HNRNPU promotes the progression of triple-negative breast cancer via RNA transcription and alternative splicing mechanisms
por: Han, Bo-yue, et al.
Publicado: (2022)

Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients
por: Takahashi, Ryuji, et al.
Publicado: (2014)

A Screened GPR1 Peptide Exerts Antitumor Effects on Triple-Negative Breast Cancer
por: Huang, Chen, et al.
Publicado: (2020)

Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer
por: Huang, Yongxiu, et al.
Publicado: (2023)

Commissioning results and operational experience of the first triple-GEM station of the CMS muon system
por: Ivone, Francesco
Publicado: (2022)

PDJ amplicon in triple negative breast cancer
por: Roesler, Alexander S., et al.
Publicado: (2023)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Integrative exploration of genomic profiles for triple negative breast cancer identifies potential drug targets
por: Wang, Xiaosheng, et al.
Publicado: (2016)

Understanding Patterns of Brain Metastasis in Triple-Negative Breast Cancer and Exploring Potential Therapeutic Targets
por: Lv, Yan, et al.
Publicado: (2021)

Unexploited opportunities for phage therapy
por: Oliveira, Hugo, et al.
Publicado: (2015)

Differential cytotoxic and radiosensitizing effects of silver nanoparticles on triple-negative breast cancer and non-triple-negative breast cells
por: Swanner, Jessica, et al.
Publicado: (2015)

Triple-Negative Breast Cancer
por: Chu, Quyen D., et al.
Publicado: (2012)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

Nullomer peptide increases immune cell infiltration and reduces tumor metabolism in triple negative breast cancer mouse model
por: Ali, Nilufar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lcpelbk9qa51ghagmm4mh6hkjc